Savannah Chrisley’s Weight Loss Website Hits a Snag: The FDA Weighs In!

Savannah Chrisley, known for her reality TV presence, is making waves with her prescription weight loss website, GoodGirlRX. Recently, the FDA issued a warning due to potentially misleading language on her site, particularly concerning the claims about GLP-1 medications like semaglutide and tirzepatide. Phrases such as “FDA-approved meds” raised eyebrows, as regulators felt they implied the products had undergone rigorous safety evaluations when they had not.

In a swift reaction to the warning, Savannah updated the wording on her website, replacing “clinically proven” with “clinically studied” and even adding disclaimers that the GLP-1 drugs aren’t FDA-approved. She assured followers that this wasn’t about patient safety but rather a matter of wording. Nevertheless, it’s a reminder that in the world of health and wellness, the line between marketing and accuracy can sometimes become a bit blurry. With all this going on, one has to wonder how far influencers will go to promote their brands—without running afoul of the law, of course!